Strategic Partnership Between AskBio and Belief BioMed
AskBio and Belief BioMed are launching an exciting partnership aimed at exploring new gene therapies for diseases that currently lack effective treatments. This collaboration is particularly focused on a liver-targeted strategy, which highlights the tremendous potential of gene therapy in addressing serious health conditions.
Advancing Gene Therapy Development
This strategic alliance brings together AskBio, a leader in gene therapy innovation, and Belief BioMed Inc., a company recognized for its advanced vector technologies. By working together, they aim to harness their unique strengths in gene therapy technology to discover new treatment options.
Lee from Project Synergy
"At AskBio, we believe that collaboration is essential for advancing gene therapy development," said Mansuo Shannon, the Chief Scientific Officer. This belief is reflected in their collaboration with Belief BioMed, a firm that has developed cutting-edge capsid technology, opening up exciting opportunities for gene therapy applications.
Cutting-Edge Gene Therapy Technologies
Based in Shanghai, China, Belief BioMed has made remarkable progress in gene therapy thanks to its robust research, development, and manufacturing capabilities. The organization is focused on aligning investigational therapies with practical applications, bringing extensive experience in viral vector technology, which is critical for the success of gene therapy.
Progress Towards Innovation
Among their recent milestones is the acceptance of a New Drug Application (NDA) for a product aimed at treating hemophilia B. This accomplishment underscores the strategic importance of their work and positions Belief BioMed as a key player in tackling genetic disorders.
Insights from Industry Leaders
Gustavo Pesquin, the CEO of AskBio, highlighted the importance of this collaboration, particularly noting the impressive credentials of Dr. Xiao, the Chairman of Belief BioMed, who has significantly influenced the gene therapy field. This partnership stands as a testament to the merging of innovative minds committed to enhancing potential gene therapy options.
Expertise Fueling Progress
Juergen Eckhardt, MD, who oversees business development at Bayer Pharmaceuticals, shared his thoughts on the technological advancements that such partnerships can enable. By combining the expertise from both companies, they can spark innovative solutions that will ultimately benefit patients around the globe.
About AskBio
Asklepios BioPharmaceutical, Inc. (AskBio), now fully integrated into Bayer AG's operations, is dedicated to developing transformative gene therapy solutions. Their extensive clinical pipeline features cutting-edge products designed to target a range of conditions, including cardiovascular diseases and neurodegenerative disorders. AskBio's pioneering strategies, supported by proprietary technologies, emphasize both the efficacy and safety of their treatments.
Bayer's Ongoing Commitment to Health and Nutrition
Bayer, a leading global player in the life sciences industry, is committed to tackling significant health and nutritional issues. With a strong portfolio of innovative products, Bayer strives to enhance quality of life for people worldwide, utilizing research and development to promote healthcare advancements.
Frequently Asked Questions
What is the focus of the collaboration between AskBio and Belief BioMed?
The partnership aims to develop innovative gene therapies for diseases with significant unmet medical needs, utilizing a liver-targeted approach.
Who leads the collaboration efforts at AskBio?
Mansuo Shannon, the Chief Scientific Officer, is at the forefront of AskBio's initiatives to explore potential therapies in collaboration with Belief BioMed.
What recent milestone has Belief BioMed achieved?
Belief BioMed recently had their New Drug Application for a gene therapy product targeting hemophilia B accepted by Chinese regulatory authorities.
How does AskBio improve its development processes?
AskBio utilizes a collaborative approach, integrating contributions from partners in the gene therapy sector to enhance their clinical pipeline.
What is Bayer's overall mission?
Bayer's mission focuses on providing health solutions and improving nutrition for global populations, with an emphasis on sustainable development across its operations.
